Silo Pharma, Inc. financial data

Symbol
SILO on Nasdaq
Industry
Pharmaceutical Preparations
Location
677 N. Washington Blvd, Sarasota, FL
State of incorporation
NV
Fiscal year end
December 31
Former names
Uppercut Brands, Inc. (to 8/14/2020), Point Capital, Inc. (to 5/14/2019), Gold Swap Inc (to 1/7/2013)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 761 % -45.8%
Debt-to-equity 29.3 % +64.7%
Return On Assets -48.4 % -19.4%
Operating Margin -5.63K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.48M shares +44.3%
Common Stock, Shares, Outstanding 4.48M shares +44.3%
Entity Public Float 5.96M USD -40.9%
Common Stock, Value, Issued 449 USD +44.4%
Weighted Average Number of Shares Outstanding, Basic 4.3M shares +38.4%
Weighted Average Number of Shares Outstanding, Diluted 4.3M shares +38.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 72.1K USD 0%
Cost of Revenue 5.84K USD 0%
Research and Development Expense 1.57M USD +37%
Operating Income (Loss) -4.06M USD +6.73%
Nonoperating Income (Expense) 342K USD +221%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.71M USD +12.5%
Income Tax Expense (Benefit) 906K USD +50.3%
Net Income (Loss) Attributable to Parent -3.78M USD +10.8%
Earnings Per Share, Basic -0.22 USD/shares -4.76%
Earnings Per Share, Diluted -0.22 USD/shares -4.76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.86M USD +2332%
Assets, Current 8.26M USD -7.39%
Intangible Assets, Net (Excluding Goodwill) 244K USD
Other Assets, Noncurrent 64.8K USD +8%
Assets 8.57M USD -4.68%
Accounts Payable, Current 144K USD
Accrued Liabilities, Current 20.1K USD
Contract with Customer, Liability, Current 72.1K USD
Liabilities, Current 1.04M USD +53.9%
Contract with Customer, Liability, Noncurrent 740K USD
Liabilities 1.78M USD +19.7%
Common Stocks, Including Additional Paid in Capital 135K USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 19.8K USD
Retained Earnings (Accumulated Deficit) -13.5M USD -38.8%
Stockholders' Equity Attributable to Parent 6.78M USD -9.53%
Liabilities and Equity 8.57M USD -4.68%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -838K USD -21%
Net Cash Provided by (Used in) Financing Activities -115K USD
Net Cash Provided by (Used in) Investing Activities 97.6K USD
Common Stock, Shares Authorized 100M shares -80%
Common Stock, Shares, Issued 4.49M shares +44.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.86M USD +2332%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.87K USD -98.9%
Deferred Tax Assets, Valuation Allowance 2.54M USD +63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.76M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid 1.88M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.88M USD
Deferred Income Tax Expense (Benefit) 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 2.54M USD +63.7%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 20.3M USD +16.6%
Deferred Tax Assets, Net of Valuation Allowance 2.54M USD +63.7%
Interest Expense 5.08K USD +13%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%